EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of the B7 family in autoimmune thyroid diseases and thyroid cancer

Ruidan Zhang, Yulu Che, Yingying Gong, Yixuan Wang, Ziwen Fang, Zongfu Pan iD

Endocrine-Related Cancer · 01.07.2026 · 33 (7)

DOI: 10.1530/erc-25-0435 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, online erschienen am 30.06.2026. Verfasst von Ruidan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Institute of Pharmacology, Zhejiang University of Technology , Hangzhou, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Autoimmune Diseases, Thyroid Diseases. Die Arbeit nennt 152 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The B7 family exerts complex and diverse immunomodulatory effects on the occurrence and development of thyroid diseases. The abnormal expression and polymorphisms of B7 family molecules in autoimmune thyroid diseases result in the disruption of immune tolerance, activation of autoreactive T cells, and thyroid tissue damage. The dysfunction of the B7 family is also closely related to the progression of thyroid cancer (TC) through remodeling the tumor microenvironment and mediating immune evasion. Of note, targeting the B7 family has become a promising strategy for TC treatment. In addition, B7 family signaling linking to immune cell subsets, tertiary lymphoid structure formation, and therapeutic response are also discussed. With the emerging findings of B7 family members in thyroid diseases, understanding the comprehensive roles and mechanisms of B7 molecules would facilitate the clinical translation of B7-based immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAutoimmune DiseasesThyroid DiseasesHumansAnimalsImmunotherapy

Stichwörter der Autor:innen

B7 familyautoimmune thyroid diseaseimmune escapeimmunotherapythyroid cancer

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Institute of Pharmacology, Zhejiang University of Technology , Hangzhou, China.
  • Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College , Hangzhou, China.
  • Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer, Zhejiang Provincial People's Hospital , Hangzhou, China.
  • Zhejiang Provincial Clinical Research Center for Head & Neck Cancer, Zhejiang Provincial People's Hospital , Hangzhou, China.

ORCID-Profile: Zongfu Pan

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Zhejiang Province

Zitieren

APA

Zhang, R., Che, Y., Gong, Y., Wang, Y., Fang, Z., & Pan, Z. (2026). The role of the B7 family in autoimmune thyroid diseases and thyroid cancer. Endocrine-Related Cancer, 33(7). https://doi.org/10.1530/erc-25-0435

Vancouver

Zhang R, Che Y, Gong Y, Wang Y, Fang Z, Pan Z. The role of the B7 family in autoimmune thyroid diseases and thyroid cancer. Endocrine-Related Cancer. 2026;33(7). doi:10.1530/erc-25-0435

BibTeX
@article{Zhang2026,
  author = {Zhang, Ruidan and Che, Yulu and Gong, Yingying and Wang, Yixuan and Fang, Ziwen and Pan, Zongfu},
  title = {The role of the B7 family in autoimmune thyroid diseases and thyroid cancer},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  volume = {33},
  number = {7},
  doi = {10.1530/erc-25-0435}
}
Kostenlos starten →